Mr. Kenneth J Sheldon, NP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 21 Clark Rd, Stony Point, NY 10980 Phone: 845-429-0676 |
Ms. Lynn M Dalton, FNP Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 7 Miller Dr, Stony Point, NY 10980 Phone: 845-786-3425 Fax: 845-786-3425 |
Ms. Joanne Ryan Martin, NP Nurse Practitioner - Pediatrics Medicare: Medicare Enrolled Practice Location: 27 Liberty Square Mall, Stony Point, NY 10980 Phone: 845-429-6900 Fax: 845-429-7050 |
Mr. William Lara, FNP-C Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 12 De Halve Maen Dr, Stony Point, NY 10980 Phone: 561-685-5919 |
Juditha J. Barthelemy, Nurse Practitioner - Family Medicare: Not Enrolled in Medicare Practice Location: 32 Pierce Dr, Stony Point, NY 10980 Phone: 845-608-2461 |
News Archive
Having high levels of anti-Müllerian hormone – a hormone that indicates the size of a woman's ovarian reserve – before the menopause is associated with an increased risk of breast cancer, new research suggests.
The call came the last week of September, when Neil Mahoney could still stagger from his bed to the porch of his mobile home to let out his boisterous yellow Lab, Ryder.
Eli Lilly and Company has provided additional perspective in response to Amylin Pharmaceuticals, Inc.'s lawsuit filed in the United States District Court for the Southern District of California.
The Johns Hopkins University, the Johns Hopkins University School of Medicine, Johns Hopkins Medicine International (JHI), the international arm of Johns Hopkins Medicine in Baltimore, USA, and Academic Medical Centre Sdn Bhd, subsidiary of Chase Perdana Sdn Bhd, a Kuala Lumpur-based private development corporation, and an associate company of Turiya Sdn Bhd, have signed an agreement to help Malaysia develop its first fully integrated private four-year graduate medical school and teaching hospital.
In addition the technique to grow the blood vessels in a 3D scaffold cuts down on the risk of transplant rejection because it uses cells from the patient. It was developed by researchers from the University of Bath's Department of Pharmacy and Pharmacology, working with colleagues at Bristol Heart Institute.
› Verified 9 days ago